Inari Medical, Inc. (NASDAQ:NARI) Receives $65.71 Consensus Price Target from Analysts

Inari Medical, Inc. (NASDAQ:NARI – Get Free Report) has earned an average rating of “Moderate Buy” from the seven analysts that are covering the company, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average twelve-month price target among […]

Leave a Reply

Your email address will not be published.

Previous post Brokerages Set Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Target Price at $28.00
Next post Pyxis Oncology, Inc. (NASDAQ:PYXS) Receives $8.50 Average PT from Brokerages